These notes draw from Brenner and Rector's The Kidney, Robbins & Cotran Pathologic Basis of Disease, Harrison's Principles of Internal Medicine 22E, Comprehensive Clinical Nephrology 7th Ed, Fischer's Mastery of Surgery, Campbell-Walsh-Wein Urology, and Tintinalli's Emergency Medicine.
Here's a quick orientation to what's covered:
1. AKI - KDIGO diagnostic criteria, pre/intra/post-renal classification, FENa interpretation, ATN stages, novel biomarkers (NGAL, KIM-1, cystatin C), hyperkalaemia management, AEIOU dialysis indications
2. Pyelonephritis/UTI - Pathogenesis (ascending vs. haematogenous), E. coli virulence (P-fimbriae), risk factors by population, VUR and reflux nephropathy, treatment by clinical scenario including pregnancy (where untreated bacteriuria carries 40% pyelonephritis risk)
3. Glomerulonephritis - Three immune mechanisms, nephritic vs. nephrotic distinction, key types (PSGN, IgA nephropathy, RPGN/Goodpasture, membranous, MPGN, lupus nephritis) with biopsy findings (LM/IF/EM), ANCA types
4. Tubulo-interstitial Diseases - ATIN triad, drug causes (NSAIDs vs. penicillins vs. checkpoint inhibitors), pathogenesis (hapten model), TINU syndrome, chronic analgesic nephropathy, papillary necrosis
5. Cystic Kidney Diseases - ADPKD (PKD1/PKD2 mutations, tolvaptan, intracranial aneurysms), ARPKD (neonatal, Potter sequence, hepatic fibrosis), nephronophthisis, VHL, tuberous sclerosis
6. Nephrotic Syndrome - Underfill vs. overfill oedema, furosemide resistance mechanism, complications (thromboembolism, infection, malnutrition), MCD/FSGS/membranous nephropathy by age, secondary causes
7. Renal Replacement Therapy - HD vs. CRRT principles, CRRT types (CVVH/CVVHD/CVVHDF), peritoneal dialysis, transplantation immunosuppression/complications, vascular access hierarchy (fistula > graft > catheter)
8. CKD - KDIGO staging (G1-G5 + A1-A3 albuminuria), uraemic syndrome by organ system, CKD-MBD pathway, SGLT2 inhibitors as disease-modifying agents, AKI vs. CKD differentiation
9. HIV and the Kidneys - HIVAN (collapsing FSGS, APOL1, ART treatment), TDF-induced Fanconi syndrome, antiretroviral nephrotoxicity table, immune complex disease, TMA, management including transplantation